FGF21 and obesity due to melanocortin 4 receptor deficiency: These effects regarding correction of metabolic imbalances were potent and beneficial making FGF19 and FGF21 exciting new opportunities for exploring novel therapies to combat the growing diabetes and obesity epidemics.